Stereospecific Synthesis of 1,4-di-O-methyl-myo-inositol (liriodendritol)

Concise syntheses and some biological activities of dl-2,5-di-O-methyl-chiro-inositol, dl-1,4-di-O-methyl-scyllo-inositol, and dl-1,6-dibromo-1,6-dideoxy-2,5-di-O-methyl-chiro-inositol

The regio- and stereospecific synthesis of O-methyl-chiro-inositols and O-methyl-scyllo-inositol was achieved, starting from p-benzoquinone. After preparing dimethoxy conduritol-B as a key compound, regiospecific bromination of the alkene moiety of dimethoxy conduritol-B and acid-catalyzed ring opening of dimethoxydiacetate conduritol-B epoxide with Ac₂ O afforded the desired new chiro-inositol derivatives and scyllo-inositol derivative, respectively. Spectroscopic methods were employed for the characterization of all synthesized compounds. The novel inositols (11-17) had effective inhibition profiles against human carbonic anhydrase isoenzymes I and II (hCA I and II) and acetylcholinesterase (AChE). The novel inositols 11-17 were found to be effective inhibitors against AChE, hCA I, and hCA II enzymes. K_i values were calculated in the range of 87.59 ± 7.011 to 237.95 ± 17.75 μM for hCA I, 65.08 ± 12.39 to 538.98 ± 61.26 μM for hCA II, and 193.28 ± 43.13 to 765.08 ± 209.77 μM for AChE, respectively. Also, due to the inhibitory effects of the novel inositols 11-17 against the tested enzymes, these novel inositols are potential drug candidates to treat some diseases such as glaucoma, epilepsy, leukemia, and Alzheimer's disease.

Synthesis of Anti–-anti (anti–-syn)-3,4:8,9-Tetraacetoxy-11-Oxa-Tricyclo [4.4.1.01,6]Undecanes

Synthesis of anti–-anti- and anti–-syn-3,4:8,9-tetraacetoxy-11-oxa-tricyclo[4.4.1.01,6] undecanes have been achieved starting from naphthalene. The Birch reduction of naphthalene gave 1,4,5,8-tetrahydro-naphthalene in high yield. 1,4,5,8-Tetrahydro-naphthalene was selectively oxidised with mCPBA to give 11-oxa-tricyclo[4.4.1.01,6]undeca-3,8-diene. OsO4 oxidation followed by acetylation furnished the corresponding tetraacetates.

A Novel and Stereospecific Synthesis of Aminocyclitol: N-Tosyldihydroconduramine E2

A stereospecific synthesis of N-tosyldihydroconduramine E2, a new aminocyclitol, has been synthesised starting from cyclohexa-1,3-diene. The photooxygenation of cyclohexa-1,3-diene afforded the bicyclic endoperoxide. Reduction of the endoperoxide with thiourea and then reaction of the bis-carbamate with p-TsNCO followed by a palladium-catalysed ionisation/cyclisation reaction, gave a vinyl oxazolidin-2-one. Oxidation of the double bond in the oxazolidin-2-one with KMnO4 followed by acetylation, gave the oxazolidinone-diacetates. Hydrolysis of the oxazolidinone ring and removal of the acetate groups gave the desired aminocyclitol, N-tosyldihydroconduramine E2.

Synthesis and Characterisation of 2,3,4a,6,8a-penta-acetoxy decahydronaphthalene from 1,2,3,4-tetrahydronaphthalen-2-ol

2,3,4a,6,8a-Penta-acetoxy decahydronaphthalene has been synthesised starting from 1,2,3,4-tetrahydronaphthalen-2-ol. The Birch reduction of 1,2,3,4-tetrahydronaphthalen-2-ol gave a high yield of 1,2,3,4,5,8-hexahydronaphthalen-2-ol which was acetylated. The OsO4 oxidation of the 1,2,3,4,5,8-hexahydronaphthalen-2-yl acetate followed by further acetylation gave the pentaacetates.

Synthesis and Characterisation of 2,3a,5,6,7a-pentaacetoxy-octahydro-1H-indene from indan-2-ol

A synthesis of 2,3a,5,6,7a-pentaacetoxyoctahydro-1 H-indene has been achieved starting from indan-2-ol. The Birch reduction of indan-2-ol gave 4,7-dihydro-2-indanol in high yield which when followed by acetylation, resulted in the corresponding acetates. The OsO4 oxidation of the 2-acetoxy-4,7-dihydroindane followed by acetylation furnished the desired pentaacetates in high yield.

Regio- and stereospecific synthesis of a new benzoconduritol-C derivative

A stereospecific synthesis of 3-(2-bromophenoxy)-1,2,3,4-tetrahydronaphthalen-1,2,4-triol (benzoconduritol-C derivative) has been achieved by a fully regio- and stereospecific rhodium catalysed reaction of oxabenzonorbornadiene in the presence of 2-bromophenol.